生物标志物 生物标志物
YoungSoo Kim1,2, Illhwan Cho2, Sunhee Lee2
1Amyloid Solution Inc., Seongnam, Gyeonggi-do, Korea, Republic of (South).
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
一种新的光化合物AS-YFluor可以检测血中的粉样蛋白-β42 (Aβ42) 寡合体. 这种阿尔茨海默病 (AD) 生物标志物检测工具对早期AD诊断和监测疾病进展具有前途.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生化学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 粉样蛋白-β42 (Aβ42) 寡合体是关键的神经毒性生物标志物,与阿尔茨海默氏症 (AD) 病原和进展有关.
- 目前用于早期AD的诊断工具和Aβ42寡合体的临床前检测是有限的,这阻碍了临床试验的有效性.
- 新型成像探针对于阐明Aβ42寡合体的作用和支持早期AD诊断至关重要.
研究的目的:
- 引入AS-YFluor,一种新型光化合物,旨在选择性检测Aβ42寡合体.
- 评估AS-YFluor在区分阿尔茨海默病患者与使用血的对照中的诊断潜力.
- 评估AS-YFluor在监测AD进展和区分各种认知状态中的实用性.
主要方法:
- 进行了体外试验,以确认AS-YFluor对Aβ42寡合物的选择性.
- 用5XFAD转基因小鼠和对照的生物样本 (脑溶解物,脑脊液,血液) 来评估诊断潜力.
- AS-YFluor应用于来自165名人类参与者的血样本 (NC,AD,MCI,非AD痴呆症) 来分析光信号.
主要成果:
- AS-YFluor对Aβ42寡合体具有很高的特异性,没有与其他蛋白种或丰富的血液蛋白质交叉反应.
- 该化合物有效地区分了来自5XFAD小鼠和对照小鼠的样本,验证了其在生物矩阵中的使用.
- 在人类研究中,AS-YFluor高精度地将AD患者与正常对照和非AD痴呆症患者区分开来 (>93%的MCI与AD/NC敏感度和特异性).
结论:
- AS-YFluor是一种新型光剂,能够选择性地检测阿尔茨海默病患者血液中的Aβ42寡合体水平.
- 该化合物显示出作为一种基于血液的诊断工具,用于早期AD检测和监测疾病进展的显著前景.
- AS-YFluor的多功能性扩展到研究寡合体行为的非临床研究应用.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516